EMEA-001239-PIP01-11 - paediatric investigation plan

brimonidine tartrate

Key facts

• Active Substance:
  brimonidine tartrate
• Therapeutic area:
  Dermatology
• Decision number:
  P/0281/2012
• PIP number:
  EMEA-001239-PIP01-11
• Pharmaceutical form(s):
  Gel
• Condition(s) / indication(s):
  Treatment of rosacea
• Route(s) of administration:
  Topical use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  21/11/2012

Decision

P/0281/2012: EMA decision of 21 November 2012 on the granting of a product-specific waiver for brimonidine tartrate (EMEA-001239-PIP01-11)

AdoptedReference Number: EMA/725996/2012